Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

95.22 -0.69 (-0.72%)
Streaming Delayed Price Updated: 2:25 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
34 35 Next >
Peak Inflation: July CPI Report Was Much Better Than Expected
(Wednesday Market Open) The report everyone was waiting for this week finally came out with the Consumer Price Index (CPI) coming in lower-than-expected and prompting equity index futures to rally.  
Via Benzinga
Equity Index Futures Slightly Higher As U.S. Dollar Retreats
(Monday Market Open) Equity index futures pointed to a higher open as the U.S. dollar retreated from Friday’s rally. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Illumina Whale Trades Spotted
A whale with a lot of money to spend has taken a noticeably bearish stance on Illumina. Looking at options history for Illumina (NASDAQ:ILMN) we detected 11 strange trades. 
Via Benzinga
Where Illumina Stands With Analysts
Illumina (NASDAQ:ILMN) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Baillie Gifford Just Doubled Down on Affirm (AFRM) Stock
Today, Baillie Gifford disclosed purchasing an additional 6.83 million shares of AFRM stock. Affirm will report earnings on Aug. 25. 
Via InvestorPlace
A Flurry Of Employment News Drops Ahead Of Friday's Jobs Report
(Thursday Market Open) The Bank of England (BoE) raised its key lending rate by 50 basis points, its biggest hike in 27 years. 
Via Benzinga
Illumina Ventures Announces Expansion of its Europe Team
From Illumina Ventures
Via Business Wire
$100 Invested In This Stock 15 Years Ago Would Be Worth $900 Today
Illumina (NASDAQ:ILMN) has outperformed the market over the past 15 years by 8.48% on an annualized basis producing an average annual return of 15.52%. Currently, Illumina has a market capitalization... 
Via Benzinga
7 Wildly Oversold S&P 500 Stocks to Buy Now
These seven S&P 500 stocks to buy have crashed amid 2022's market turmoil and are now set for a swift rebound. 
Via InvestorPlace
Illumina Whale Trades Spotted
Someone with a lot of money to spend has taken a bullish stance on Illumina (NASDAQ:ILMN). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
CD Genomics Unveils Chloroplast DNA (cpDNA) Sequencing Service for Your Biological Research
Via Press Release Distribution Service
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
Illumina (NASDAQ:ILMN) has outperformed the market over the past 10 years by 4.8% on an annualized basis producing an average annual return of 15.31%. Currently, Illumina has a market capitalization of... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2022
Upgrades 
Via Benzinga
Global Thyroid Cancer Testing Market in-Depth Progress Research 2022-2031 Thermo Fisher Scientific, Agilent Technologies, GE Healthcare, Abbott Laboratories
The intelligent report on the global Thyroid Cancer Testing market provides deep analysis of the Thyroid Cancer Testing industry segments including product type, application, special geographies and... 
Via SBWire
Topics Supply Chain
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022
Upgrades 
Via Benzinga
Citigroup Maintains Neutral Rating for Illumina: Here's What You Need To Know
Citigroup has decided to maintain its Neutral rating of Illumina (NASDAQ:ILMN) and lower its price target from $325.00 to $220.00. Shares of Illumina are trading up 0.17% over the last 24 hours, at... 
Via Benzinga
The 3 Best Retirement Stocks for Gen-Z Investors
Older generations are showing their worry and providing a huge opportunity in the market's best retirement stocks for Gen-Z investors to buy 
Via InvestorPlace
3 Biotech Stocks to Sell Now
These biotech stocks remain vulnerable to more downside. Their charts remain broken and resistance looms ominously overhead. 
Via InvestorPlace
7 Beaten-Down S&P 500 Stocks to Buy Before They Rebound
With the market becoming more convinced that a "soft landing" is in the cards, there are many good, beaten-down S&P 500 stocks to buy. 
Via InvestorPlace
Here's How Much You Would Have Made Owning Illumina Stock In The Last 15 Years
Illumina (NASDAQ:ILMN) has outperformed the market over the past 15 years by 9.39% on an annualized basis producing an average annual return of 15.68%. Currently, Illumina has a market capitalization... 
Via Benzinga
Community Health Network and Grail Partner to Offer Galleri® Multi-Cancer Early Detection Test in Central Indiana
From GRAIL
Via Business Wire
Genomics in Cancer Care Market Growth Opportunities Competitive Analysis Forecast Report 2022-2029
Via AB Newswire
NonExomics Unveils Technology to Decode Dark Genome for Diagnosis and Treatment of Diseases Like Cancer
Beverly, Massachusetts--(Newsfile Corp. - June 20, 2022) - NonExomics has announced the launch of new technology to explore the dark... 
Via Newsfile
Topics Artificial Intelligence
Music Beats Cancer Hosts Reception at BIO International Convention in San Diego
Via AB Newswire
If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today
Illumina (NASDAQ:ILMN) has outperformed the market over the past 10 years by 6.06% on an annualized basis producing an average annual return of 16.76%. Currently, Illumina has a market capitalization... 
Via Benzinga
Here’s Why I’m Not Buying Moderna-Backer Scottish Mortgage, Yet!
Scottish Mortgage Investment Trust shares have been on a downward track this year after investors moved away from growth stocks. 
Via Talk Markets
After-Hours Movers; DocuSign crashes over 20%
DocuSign crashes over 20% after Q1 earnings miss; Illumina slips 6% as company CFO steps down, and more from after hours. 
Via Talk Markets
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares rose 9.4% to $0.81 during Thursday's after-market session. The market value of their outstanding shares is at $2.8 million. 
Via Benzinga
Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions
SOURCE: Illumina 
Via 3BL Media
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.